Kassebaum's S 1477 focuses on improved FDA processes rather than third-party reviews.
This article was originally published in The Tan Sheet
Executive Summary
KASSEBAUM URGES IMPROVED FDA REGULATORY PROCESS INSTEAD OF THIRD PARTY reviews in a Dec. 14 interview on National Public Radio's "Diane Rehm Show." Senate Labor & Human Resources Committee Chairman Nancy Kassebaum (R-Kan.) suggested that Congress should focus on improving the agency's regulatory procedures rather than on contracting outside third parties for application reviews.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning